01099 國藥控股
按盘价 
19.680 -0.740 (-3.624%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | 1.827% | 1.816% | 2.420% | 2.435% | 2.400% |
| 股东资金回报率 (%) | 8.788% | 9.187% | 12.694% | 13.121% | 13.123% |
| 资本运用回报率 (%) | 4.981% | 4.949% | 6.380% | 6.568% | 6.682% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 7.245% | 7.571% | 8.132% | 8.591% | 8.454% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 3.451% | 3.398% | 4.235% | 4.501% | 4.464% |
| 税前边际利润率 (%) | 2.573% | 2.395% | 3.271% | 3.362% | 3.263% |
| 纯利率 (%) | 1.244% | 1.206% | 1.518% | 1.544% | 1.489% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 1.406 X | 1.388 X | 1.395 X | 1.359 X | 1.327 X |
| 速动比率 (X) | 1.149 X | 1.139 X | 1.146 X | 1.100 X | 1.092 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 65.632% | 67.750% | 68.618% | 69.825% | 70.289% |
| 总债项 / 总资产比率 (%) | 18.178% | 19.445% | 19.244% | 19.078% | 20.383% |
| 净债项 / 总资产比率 (%) | 5.678% | 5.619% | 2.601% | 3.939% | 7.405% |
| 总债项 / 股东资金比率 (%) | 84.524% | 96.834% | 98.927% | 102.235% | 110.474% |
| 长期债项 / 股东资金比率 (%) | 7.314% | 15.081% | 23.135% | 21.973% | 18.855% |
| 净债项 / 股东资金比率 (%) | 26.401% | 27.981% | 13.372% | 21.109% | 40.136% |
| 净现金 / (债项) ($) | (221.64亿) | (220.73亿) | (99.73亿) | (143.69亿) | (248.39亿) |
| 每股净现金 / (债项) ($) | (7.102) | (7.073) | (3.196) | (4.604) | (7.959) |
| 总债项 / 资本运用比率 (%) | 49.403% | 53.621% | 51.994% | 53.608% | 58.884% |
| 利息盈利率 (X) | 7.434 X | 6.121 X | 7.600 X | 6.273 X | 5.526 X |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 42.998日 | 41.341日 | 40.277日 | 40.652日 | 37.719日 |
| 应收贸易帐周转率日数 (日) | 128.791日 | 120.113日 | 108.353日 | 112.759日 | 110.936日 |
| 应付贸易帐周转率日数 (日) | 95.620日 | 92.963日 | 86.794日 | 87.760日 | 84.433日 |
| 备注： | 实时报价更新时间为24/03/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 7,155,094 |
| 增长率 | 1.495% |
| 每股盈利/(亏损) | RMB 2.290 |
| 每股账面资产净值 (¥) | RMB 26.902 |